
8-K
1
tm2018001d1_8k.htm
8-K



     





 

 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):
April 28, 2020

 

 

 

DFP HEALTHCARE ACQUISITIONS CORP.

(Exact name of registrant as specified in
its charter)

 

 

 



    Delaware
    001-39248
    84-3562323

    (State or other jurisdiction
of incorporation)
    (Commission
File Number)
    (IRS Employer
Identification No.)

 

780 Third Avenue, 37th Floor

New York, New York 10017

(Address of principal executive offices,
including zip code)

 

Registrant’s telephone number, including
area code: (212) 551-1600

 

Not Applicable
(Former name or former address, if changed since last report)

 

 

 

Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

 



    ¨
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     
     

    ¨
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     
     

    ¨
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     
     

    ¨
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging
growth company x

 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨

 

Securities registered pursuant to Section 12(b) of the Act:

 



    Title of each class
     
    Trading Symbol(s)
     
    Name of each exchange on which registered

    
        Units,
        each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
         
     
    DFPHU
     
    The Nasdaq Stock Market LLC

    
        Class
        A common stock, par value $0.0001 per share
         
     
    DFPH
     
    The Nasdaq Stock Market LLC

    Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
     
    DFPHW
     
    The Nasdaq Stock Market LLC

 



 





     
     
    

 


Item 8.01.Other Events.

  

On April 28, 2020,
DFP Healthcare Acquisitions Corp. (the “Company”) issued a press release, a copy of which is attached as Exhibit 99.1
to this Current Report on Form 8-K, announcing that the holders of the Company’s units (the “Units”) may elect
to separately trade the shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), and
warrants (the “Warrants”) included in the Units commencing on or about May 1, 2020. Each Unit consists of one share
of Class A Common Stock and one-fourth of one redeemable Warrant to purchase one share of Class A Common Stock. Any Units not separated
will continue to trade on The Nasdaq Capital Market under the symbol “DFPHU”, and the Class A Common Stock and Warrants
will separately trade on The Nasdaq Capital Market under the symbols “DFPH” and “DFPHW”, respectively.  No
fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need
to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate
the Units into shares of Class A Common Stock and Warrants.

 


Item 9.01Financial Statements and Exhibits.

 



     
    (d)
    Exhibits

 

EXHIBIT INDEX

 



    Exhibit No.
     
    Description

    99.1 
     
    Press Release, dated April 28, 2020.

 



     
     
    

 

SIGNATURE

 

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

 



     
    DFP HEALTHCARE ACQUISITIONS CORP.

     
     
     

     
     
     

     
    By: 
    /s/ Christopher Wolfe
     

     
     
    Name: 
    Christopher Wolfe
     

     
     
    Title:
    Chief Financial Officer

     
     
     

    Dated: April 28, 2020
     
     

 




     
    

 




